Whittier Trust’s CureVac CVAC Stock Holding History

Whittier Trust’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-585	Closed	-$1.99K	–	1553
2024 Q2	$1.99K	Buy	+585	New	+$1.91K	﹤0.01%	1433

Other funds holding CVAC

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Whittier Trust's CVAC Position: Q3 2024 in Review

Whittier Trust sold out of CureVac (CVAC) in Q3 2024, closing a stake of 585 shares — an estimated $1.99K sold.

Whittier Trust first reported a position in CVAC in Q2 2024 and held it in 1 quarter. The position peaked at $1.99K in Q2 2024. 81 funds tracked by Wall St. Rank hold CVAC as of Q3 2024.

Whittier Trust reported no remaining CureVac position as of Q3 2024 after selling out during the quarter.
Whittier Trust sold 585 CureVac shares in Q3 2024, an estimated $1.99K.
Whittier Trust first reported a position in CureVac in Q2 2024 and held it in 1 quarter.
Whittier Trust's CureVac position peaked at $1.99K in Q2 2024.
81 funds tracked by Wall St. Rank held CureVac as of Q3 2024.

Based on Whittier Trust's 13F filing for Q3 2024, filed 21 Oct 2024.